NCT00184691View on ClinicalTrials.gov

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Foetal Growth ProblemSmall for Gestational Age
Interventions
DRUG

somatropin

Trial Locations (13)

11009

Novo Nordisk Investigational Site, Cadiz

14004

Novo Nordisk Investigational Site, Córdoba

15705

Novo Nordisk Investigational Site, Santiago de Compostela

18012

Novo Nordisk Investigational Site, Granada

28009

Novo Nordisk Investigational Site, Madrid

28046

Novo Nordisk Investigational Site, Madrid

29011

Novo Nordisk Investigational Site, Málaga

30120

Novo Nordisk Investigational Site, El Palmar

38010

Novo Nordisk Investigational Site, Santa Cruz de Tenerife

41013

Novo Nordisk Investigational Site, Seville

48903

Novo Nordisk Investigational Site, Barakaldo

08035

Novo Nordisk Investigational Site, Barcelona

08950

Novo Nordisk Investigational Site, Esplugues Llobregat

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00184691 - Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years | Biotech Hunter | Biotech Hunter